Prescription depressants

Tianeptine, an antidepressant that can have similar effects on the body as opioids, is sold as a dietary supplement at gas stations and convenience stores across the country. It’s often marketed as an “alternative medicine” that can relieve pain, reduce depression symptoms, and address anxiety. While not approved for medical use in the United States, it is approved in some European, Asian, and Latin American countries.

One of the crucial components in reducing drug experimentation and addiction is ensuring people do not have easy access to drugs. To that point, prescription drug take-back programs may be one of America's best efforts for reducing youth exposure to addictive pharmaceuticals.

Prescription drug monitoring programs (PDMPs) rose to prominence in the early-2000s as a watchdog system for curtailing overprescribing and the diversion of pharmaceuticals into the hands of addicts, not patients. Twenty years later, research shows PDMPs only work when drug rehab is included for those addicted. When rehab is not included alongside PDMPs, addicts seek hard street drugs, and overdoses follow.

Drug addiction affects everyone differently. While such a crisis is unique to the individual, certain demographics face challenges one might not find elsewhere. For example, military veterans who become addicted to drugs and alcohol often feel disinclined to discuss their problems or seek addiction treatment.

A significant percentage of young people undergo their first exposure to mind-altering drugs by simply consuming leftover medications they found in the family medicine cabinet or elsewhere in the home. Because it is far easier to prevent someone from using drugs than treat addiction once the person is hooked, families should commit to creating substance-free homes.